drugset / Trial / NCT00695344
Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate if there is a significantly less incidence of major clinical events due to graft vascular illness in recipients of a cardiac transplant on treatment with an immunosuppressive combination, which includes Everolimus, compared to those that continue the previously used immunosuppressive treatment.
Timeline
- Start
- 2006-01
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | Oral |
| Comparator | Azathioprine | Small molecule | — | — |
| Comparator | Mycophenolate Mofetil | Small molecule | — | — |
Indications
No indication recorded.